Gilead Sciences Inc (GILD)

62.92 -0.41  -0.65% NASDAQ Nov 14, 09:58 Delayed 2m USD

Gilead Sciences Free Cash Flow (Quarterly):

2.699B for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 2.699B
June 30, 2019 2.036B
March 31, 2019 1.207B
Dec. 31, 2018 2.097B
Sept. 30, 2018 2.045B
June 30, 2018 1.276B
March 31, 2018 2.058B
Dec. 31, 2017 2.533B
Sept. 30, 2017 2.565B
June 30, 2017 3.403B
March 31, 2017 2.807B
Dec. 31, 2016 3.37B
Sept. 30, 2016 4.195B
June 30, 2016 4.781B
March 31, 2016 3.953B
Dec. 31, 2015 5.629B
Sept. 30, 2015 3.81B
June 30, 2015 5.487B
March 31, 2015 5.577B
Dec. 31, 2014 2.854B
Sept. 30, 2014 3.909B
June 30, 2014 4.094B
March 31, 2014 1.404B
Dec. 31, 2013 658.11M
Sept. 30, 2013 715.92M
   
June 30, 2013 907.73M
March 31, 2013 633.25M
Dec. 31, 2012 436.19M
Sept. 30, 2012 678.78M
June 30, 2012 1.253B
March 31, 2012 429.77M
Dec. 31, 2011 952.00M
Sept. 30, 2011 832.82M
June 30, 2011 916.62M
March 31, 2011 805.67M
Dec. 31, 2010 701.48M
Sept. 30, 2010 728.62M
June 30, 2010 683.03M
March 31, 2010 658.90M
Dec. 31, 2009 928.29M
Sept. 30, 2009 842.41M
June 30, 2009 602.04M
March 31, 2009 477.26M
Dec. 31, 2008 543.10M
Sept. 30, 2008 480.65M
June 30, 2008 415.87M
March 31, 2008 588.76M
Dec. 31, 2007 492.66M
Sept. 30, 2007 238.70M
June 30, 2007 489.93M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Free Cash Flow

Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More

Advertisement

Free Cash Flow (Quarterly) Benchmarks

Benchmarks
Amgen Inc 3.207B
Biogen Inc 1.605B
Celgene Corp 1.704B

Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum 1.207B Mar 2019
Maximum 5.629B Dec 2015
Average 3.219B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.